XML 29 R17.htm IDEA: XBRL DOCUMENT v3.25.2
STOCKHOLDERS EQUITY
6 Months Ended
Jun. 30, 2025
STOCKHOLDERS EQUITY  
STOCKHOLDERS' EQUITY

NOTE 10 – STOCKHOLDERS’ EQUITY

 

Preferred Stock - The Company is authorized to issue 10,000,000 shares of “blank check” preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s Board of Directors. On August 30, 2024, the Company amended and restated its Certificate of Incorporation to designate 5,000,000 shares of the Preferred Stock as a newly-designed Series A Preferred Stock. Series A Preferred Stock will have a $1.00 par value, while the remainder of preferred stock will remain at $0.0001. At June 30, 2025 and December 31, 2024, there were 2,107,879 and 1,607,886, respectively, shares of preferred stock issued or outstanding, with issuances of Series A Preferred Stock coming from conversions of debts and fees payable to Series A Preferred Stock.

 

Common Stock - The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At June 30, 2025 and December 31, 2024, there were 14,917,944 and 14,958,817, respectively shares of common stock issued and outstanding. On April 13, 2024, the Company’s Board of Directors unanimously voted to approve a discretionary stock repurchase program. Under the program, the Company may purchase up to $2,000,000 of its common stock over the next 24 months, as market conditions warrant. The shares may be repurchased in the open market or in privately negotiated transactions, at prices that the Company deems appropriate and subject to market conditions, applicable law and other factors deemed relevant in the Company’s sole discretion. At June 30, 2025, the Company has repurchased a total of 111,777 shares of its common stock, which represents a combination of 31,777 open market purchases and 80,000 shares purchase through private transactions.

 

Dividends – The Board of Directors approved and declared a dividend of $0.0025 per share on January 30, 2025. This resulted in a total dividend of $37,410 being paid on July 14, 2025 to common stockholders on record at June 30, 2025.

 

Stock-based Compensation - Effective December 17, 2024, the Board of Directors of the Company adopted a board compensation plan. The plan provides for the allocation and issuance of stock warrants to directors of the Company for annual compensation for their services on the Company’s Board of Directors.

 

Total stock-based compensation expense for warrants to directors was $6,907 and $0 for both the three month periods ended June 30, 2025 and 2024, respectively. Total stock-based compensation expense for warrants to directors was $13,813 and $0 for both the six month periods ended June 30, 2025 and 2024, respectively. Stock-based compensation expense was charged to general and administrative expense.

 

As of June 30, 2025 and December 31, 2024, the Company has $55,252 and $75,971, respectively, of unrecognized compensation cost related to unvested stock warrants granted and outstanding, net of estimated forfeitures. The cost is expected to be recognized on a weighted average basis over a period of three years.

 

The following table summarizes the activity of our stock warrants for the periods ended June 30, 2025 and December 31, 2024:

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

Number of

 

 

Average

 

 

Contractual

 

 

Intrinsic

 

 

 

Warrants

 

 

Exercise Price

 

 

Life in Years

 

 

Value

 

Outstanding December 31, 2024

 

 

225,000

 

 

$1

 

 

 

2.96

 

 

$82,878

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited or Expired

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding March 31, 2025

 

 

225,000

 

 

$1

 

 

 

2.71

 

 

$67,470

 

Exercisable (Vested) – March 31, 2025

 

 

225,000

 

 

$1

 

 

 

2.71

 

 

$67,470

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited or Expired

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding June 30, 2025

 

 

225,000

 

 

$1

 

 

 

2.46

 

 

$97,808

 

Exercisable (Vested) – June 30, 2025

 

 

225,000

 

 

$1

 

 

 

2.46

 

 

$97,808